Eduardo Mysler

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
   2022/11/10 by Josef S Smolen, Robert Landewé, Robert B M Landewé +63 · 51 citations
   Medicine · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Biosimilars and Bioanalytical Methods #Hemophilia Treatment and Research
2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
   2020/01/22 by Josef S Smolen, Robert Landewé, Robert B M Landewé +62 · 32 citations
   Medicine · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Biosimilars and Bioanalytical Methods #Systemic Lupus Erythematosus Research
3. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
   2011/05/04 by Naomi Schlesinger, Eduardo Mysler, Hsiao-Yi Lin +10 · 25 citations
   Medicine · Biochemistry, Genetics and Molecular Biology · #Gout, Hyperuricemia, Uric Acid #Rheumatoid Arthritis Research and Therapies #Inflammasome and immune disorders